Medivir AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Medivir AB (publ) Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Medivir AB (publ), with an average price target of kr10.23. This potential gain of 235.41 percent from the previous closing price in May, 2024 is calculated on a high forecast of kr54.00 and a low estimate of kr8.00. If you are interested in MVIR stock, it is important to also consider its competitors.
235.41% Upside
Medivir AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Price for Medivir AB (publ) has grown by 100.00%, going from kr0.00 to kr0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach kr3.24 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Medivir AB (publ) will be 100.00%.
Medivir AB (publ) Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Medivir AB (publ)'s Revenue has decreased by 64.98%, from kr21.79M to kr7.63M. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach kr21.86M – an increase of 186.51%. Over the next seven years, experts anticipate that Revenue growth for Medivir AB (publ) will be 389.24%.
.jpg)
Medivir AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Medivir AB (publ)'s EBITDA has grown, increasing from kr-57.84M to kr-92.62M – an increase of 60.13%. According to 2 major analysts, Medivir AB (publ)'s EBITDA will fall by 138.33% in the next year, reaching kr35.50M. Over the next seven years, the pros' prediction is EBITDAof kr-132.81M, which would mean a seven-year growth forecast of 43.40%.
Medivir AB (publ) EBIT Forecast for 2023 - 2025 - 2030
Medivir AB (publ)'s EBIT has increased by 56.01% In the last three years, going from kr-59.45M to kr-92.75M. In the next year, 4 analysts estimate that Medivir AB (publ)'s EBIT will decrease by 55.15%, reaching kr-41.60M. According to professional forecasts, in 2030, Medivir AB (publ)'s EBIT will decrease by 3029.05%, reaching kr2.72B.
Medivir AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, EPS for Medivir AB (publ) has grown by 100.00%, going from kr-1.75 to kr0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach kr-1.01 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Medivir AB (publ) will be 100.00%.
.jpg)